Yang Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yang Yang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Fangbao Ding
Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200092, China
1 shared publication - Fengqing Hu
Department of Cardiothoracic Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Haibo Xiao
Department of Endodontics, Changsha Stomatological Hospital, Changsha, China
1 shared publication Huiling Lai
Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
1 shared publicationJianfeng Zhou
Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
1 shared publication- Ju Mei
Department of Cardiothoracic Surgery, Xinhua Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
1 shared publication
Latest Publications
- 1 May 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 460 (3) , 703-708
USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer
- 1 May 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 460 (3) , 703-708
USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer
- 1 April 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 459 (2) , 333-339
Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance
- 1 April 2015
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 459 (2) , 333-339
Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance